ES2389864T3 - Composiciones de polvo seco y sistemas para la vacunación de aves de corral - Google Patents

Composiciones de polvo seco y sistemas para la vacunación de aves de corral Download PDF

Info

Publication number
ES2389864T3
ES2389864T3 ES07711957T ES07711957T ES2389864T3 ES 2389864 T3 ES2389864 T3 ES 2389864T3 ES 07711957 T ES07711957 T ES 07711957T ES 07711957 T ES07711957 T ES 07711957T ES 2389864 T3 ES2389864 T3 ES 2389864T3
Authority
ES
Spain
Prior art keywords
virus
vaccination
dry powder
poultry
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES07711957T
Other languages
English (en)
Spanish (es)
Inventor
Jean Paul Remon
Chris Vervaet
Evy Corbanie
Johannes Hubertus Henricus Van Eck
Wilhelmus Johannes Mathernus Landman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ghent University
Original Assignee
Ghent University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ghent University filed Critical Ghent University
Application granted granted Critical
Publication of ES2389864T3 publication Critical patent/ES2389864T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/544—Mucosal route to the airways
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18111—Avulavirus, e.g. Newcastle disease virus
    • C12N2760/18134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Otolaryngology (AREA)
  • Dispersion Chemistry (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Biotechnology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
ES07711957T 2006-03-15 2007-03-15 Composiciones de polvo seco y sistemas para la vacunación de aves de corral Active ES2389864T3 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP06005245A EP1834651A1 (en) 2006-03-15 2006-03-15 Compositions and methods for veterinary vaccination
EP06005245 2006-03-15
PCT/EP2007/002284 WO2007104562A1 (en) 2006-03-15 2007-03-15 Dry powder compositions and systems for poultry vaccination

Publications (1)

Publication Number Publication Date
ES2389864T3 true ES2389864T3 (es) 2012-11-02

Family

ID=37564170

Family Applications (1)

Application Number Title Priority Date Filing Date
ES07711957T Active ES2389864T3 (es) 2006-03-15 2007-03-15 Composiciones de polvo seco y sistemas para la vacunación de aves de corral

Country Status (14)

Country Link
US (2) US20090041852A1 (enExample)
EP (2) EP1834651A1 (enExample)
JP (1) JP2009529558A (enExample)
CN (1) CN101415437A (enExample)
BR (1) BRPI0708983A2 (enExample)
DK (1) DK1993605T3 (enExample)
ES (1) ES2389864T3 (enExample)
MX (1) MX2008011701A (enExample)
PL (1) PL1993605T3 (enExample)
PT (1) PT1993605E (enExample)
RU (1) RU2450828C2 (enExample)
SI (1) SI1993605T1 (enExample)
UA (1) UA96754C2 (enExample)
WO (1) WO2007104562A1 (enExample)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1834651A1 (en) * 2006-03-15 2007-09-19 Universiteit Gent Compositions and methods for veterinary vaccination
ES2661038T3 (es) * 2008-03-24 2018-03-27 Intervet International B.V. Vacunas encapsuladas para la vacunación oral y de refuerzo de peces y otros animales
US8778384B2 (en) 2008-03-24 2014-07-15 Advanced Bionutrition Corporation Compositions and methods for encapsulating vaccines for the oral vaccination and boostering of fish and other animals
WO2010037027A2 (en) * 2008-09-26 2010-04-01 Auburn University Immunization of avians by mucosal administration of non-replicating vectored vaccines
ES2661215T3 (es) 2009-05-20 2018-03-28 Aeras Composiciones víricas; inmunógenas; secadas por pulverización; estables
JP5550277B2 (ja) * 2009-07-23 2014-07-16 長谷川香料株式会社 保存安定性に優れた粉末組成物
KR101745029B1 (ko) * 2009-08-21 2017-06-08 메리얼 인코포레이티드 재조합 조류 파라믹소바이러스 백신 및 이의 제조 및 사용 방법
WO2011041788A2 (en) * 2009-10-02 2011-04-07 The Trustees Of Columbia University In The City Of New York Turkey viral hepatitis virus and uses thereof
CN102772799A (zh) * 2012-05-31 2012-11-14 郑州后羿制药有限公司 一种鸭病毒性肝炎、鸭瘟二联卵黄抗体冻干粉及其制备方法
CN103083659B (zh) * 2013-01-18 2015-05-13 北京华夏兴洋生物科技有限公司 新型无油佐剂制备方法及用途
EP3512939B1 (en) 2016-09-16 2026-06-17 Leukocare AG A novel method for obtaining efficient viral vector-based compositions for vaccination or gene therapy
US11510871B2 (en) 2016-09-16 2022-11-29 Leukocare Ag Method for producing low viscous and highly concentrated biopharmaceutical drug products in liquid formulation
CN107019707A (zh) * 2017-03-14 2017-08-08 杨凌绿方生物工程有限公司 一种鸡胚成纤维细胞产品冻干工艺方法
TR201718859A2 (tr) * 2017-11-27 2017-12-21 Bilge Kaan Tekelioglu Siğirlarin gangrenli̇ nezlesi̇ i̇çi̇n aşi ve aşinin üreti̇m yöntemi̇
CN109260467B (zh) * 2018-08-17 2021-08-20 山东信得科技股份有限公司 一种预防雏鹅痛风症状的疫苗
EP3698773A1 (en) 2019-02-21 2020-08-26 Università degli Studi di Parma Composition and manufacturing of powders containing nanoadjuvants for mucosal vaccination
CN113599513A (zh) * 2020-10-23 2021-11-05 青岛大学 一种适用于咽喉部接种的新型冠状病毒疫苗的制备方法及接种方法
IL313015A (en) * 2021-11-25 2024-07-01 Orexo Ab A pharmaceutical preparation that includes biopharmaceutical drug compounds

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58105310U (ja) * 1982-01-11 1983-07-18 貝原　睦衛 ひよこ用ワクチン点眼装置
JPS5924019U (ja) * 1982-08-05 1984-02-15 イカリ消毒株式会社 動物用ワクチン投与装置
RU2035909C1 (ru) * 1993-06-02 1995-05-27 Виноходов Владимир Олегович Препарат для профилактики и лечения заболеваний птиц
GB9607035D0 (en) * 1996-04-03 1996-06-05 Andaris Ltd Spray-dried microparticles as therapeutic vehicles
SE9801288D0 (sv) * 1998-04-14 1998-04-14 Astra Ab Vaccine delivery system and metod of production
US6651655B1 (en) * 2000-01-18 2003-11-25 Quadrant Technologies Limited Inhaled vaccines
WO2005123131A2 (en) * 2004-06-14 2005-12-29 Medimmune Vaccines, Inc. High pressure spray-dry of bioactive materials
JP2006512102A (ja) * 2002-04-11 2006-04-13 メディミューン・ヴァクシンズ・インコーポレーテッド 噴霧乾燥による生物活性材料の防腐
AU2002951692A0 (en) * 2002-09-23 2002-10-17 Vital Biotech (Hong Kong) Limited Improvements in or relating to vaccines
KR20050088175A (ko) * 2002-12-17 2005-09-02 메드이뮨 백신즈 인코포레이티드 생물활성 물질의 고압 분무 건조
US20050207983A1 (en) * 2004-03-05 2005-09-22 Pulmatrix, Inc. Formulations decreasing particle exhalation
EP1834651A1 (en) * 2006-03-15 2007-09-19 Universiteit Gent Compositions and methods for veterinary vaccination

Also Published As

Publication number Publication date
WO2007104562A1 (en) 2007-09-20
SI1993605T1 (sl) 2012-11-30
US20090041852A1 (en) 2009-02-12
RU2008140745A (ru) 2010-04-20
US20110150940A1 (en) 2011-06-23
BRPI0708983A2 (pt) 2011-06-21
MX2008011701A (es) 2008-11-27
EP1993605B1 (en) 2012-06-27
PL1993605T3 (pl) 2012-12-31
CN101415437A (zh) 2009-04-22
PT1993605E (pt) 2012-09-17
JP2009529558A (ja) 2009-08-20
DK1993605T3 (da) 2012-09-10
UA96754C2 (ru) 2011-12-12
EP1993605A1 (en) 2008-11-26
RU2450828C2 (ru) 2012-05-20
EP1834651A1 (en) 2007-09-19

Similar Documents

Publication Publication Date Title
EP1993605B1 (en) Dry powder compositions and systems for poultry vaccination
RU2339400C2 (ru) Стабилизированная вакцинная композиция для стимулирования иммунного ответа и способ ее получения
Audouy et al. Development of a dried influenza whole inactivated virus vaccine for pulmonary immunization
Bahamondez-Canas et al. Intranasal immunization with dry powder vaccines
ES2897659T3 (es) Formulaciones de vacunas térmicamente estables, procesos y microagujas que incluyen las formulaciones de vacunas
JP6896802B2 (ja) 室温安定であるワクチンの乾燥製剤
KR101960102B1 (ko) 비강내 전달을 위한 방법 및 조성물
Calderon-Nieva et al. Veterinary vaccine nanotechnology: pulmonary and nasal delivery in livestock animals
Murugappan et al. Physical and immunogenic stability of spray freeze-dried influenza vaccine powder for pulmonary delivery: comparison of inulin, dextran, or a mixture of dextran and trehalose as protectants
Fawzy et al. Nanoparticles as a novel and promising antiviral platform in veterinary medicine
PT1954308E (pt) Estabilizadores para vacinas liofilizadas
JP6300827B2 (ja) ケイ化ウイルスを含む免疫原性組成物および使用の方法
JP2011514337A (ja) 糖ガラス化ウィルス様粒子（ｖｌｐ）
WO2014066856A9 (en) Inhalable influenza vaccine compositions and methods
ES2626297T3 (es) Preservación asistida por vacío de productos biológicos, en particular de vacunas
Tomar et al. Passive inhalation of dry powder influenza vaccine formulations completely protects chickens against H5N1 lethal viral challenge
Chen et al. Nanotechnologies applied in biomedical vaccines
ES2676833T3 (es) Vacuna para proteger a un rumiante contra la neumonía causada por Pasteurella multocida
ES2731636T3 (es) Composición adyuvante que contiene citrulina
JPWO2019021957A1 (ja) 点鼻用乾燥粉末医薬組成物
Shawky et al. Comparative protective efficiency of different stabilizers for live Newcastle Disease Virus vaccine production
ES2744126T3 (es) Vacuna contra la gripe felina y método de uso
Bajrovic Development and Characterization of Thermostable Thin Films as a Novel Vaccine Dosage Form
US20070098740A1 (en) Stabilisation of viral microparticles
AU2003264166A1 (en) Improvements in or relating to vaccines